Back
Evoke Pharma Stock Predictions
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
EVOK
Evoke Pharma
Last Price:
5.35
Seasonality Move:
-7.28%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in the Next Big AI Disruptor Today
Learn MoreEvoke Pharma Stock Forecast
- Over the next 52 weeks, Evoke Pharma has on average historically risen by 1.1% based on the past 11 years of stock performance.
- Evoke Pharma has risen higher in 2 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 18.18%
-
Is Evoke Pharma Stock Undervalued?
The current Evoke Pharma [EVOK] share price is $5.25. The Score for EVOK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - EVOK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Evoke Pharma Stock Go Up Next Year?
- Over the next 52 weeks, Evoke Pharma has on average historically risen by 1.1% based on the past 11 years of stock performance.
Evoke Pharma Stock Rating
Sell
37
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma overpriced?
- Evoke Pharma has risen higher in 2 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 18.18%
Evoke Pharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
evokepharma.com
52-Week Data
52-Week High:
17.88
52-Week Low:
3.54
Prediction Charts
Market Cap:
3.86M
Price in USD:
5.25
Volume:
218.57K
Beta:
0.62
Technical Analysis
SMA50:
4.83
SMA100:
5.51
SMA200:
6.81
52-Wk Change:
-67.11%
Stock Predictions
-
Is Evoke Pharma stock public?
Yes, Evoke Pharma is a publicly traded company. -
What is the Evoke Pharma stock quote today?
The Evoke Pharma stock price is 5.25 USD today. -
How to buy Evoke Pharma stock online?
You can buy Evoke Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-17 | 4.14 | 4.36 | 4.39 | 4.14 |
| Sep-18 | 4.13 | 4.24 | 4.40 | 4.13 |
| Sep-19 | 4.39 | 4.44 | 4.88 | 4.30 |
| Sep-20 | 4.41 | 4.51 | 4.72 | 4.40 |
| Sep-23 | 4.70 | 5.26 | 5.31 | 4.25 |
| Sep-24 | 5.07 | 5.00 | 5.26 | 4.85 |
| Sep-25 | 5.12 | 4.80 | 5.35 | 4.80 |
| Sep-26 | 4.90 | 5.08 | 5.25 | 4.72 |
| Sep-27 | 4.78 | 4.81 | 5.08 | 4.76 |
| Sep-30 | 4.74 | 4.76 | 5.05 | 4.56 |
| Oct-1 | 4.90 | 4.87 | 4.90 | 4.51 |
| Oct-2 | 5.19 | 4.95 | 5.19 | 4.73 |
| Oct-3 | 4.95 | 5.20 | 5.25 | 4.92 |
| Oct-4 | 5.05 | 5.25 | 6.00 | 4.91 |
Evoke Pharma Earnings
Evoke Pharma Earnings Report: Per Share Evoke Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.
Evoke Pharma Forecast Revenue Growth
Evoke Pharma Stock Analysis: Historical quarterly revenues per share for Evoke Pharma and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $24.34 per share, and an increase next year of $2.66 per share.
* Evoke Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.